CAMBRIDGE, Mass., Aug. 25, 2022 -- Aktis Oncology, a biotechnology company discovering and developing novel classes of targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, today announced...
Sean McCarthy is participating in a panel at the Financing Solutions and Strategies for Life Sciences Conference in New York City
News | 10. 19. 2009
